Evidence map›Paper›PMID 19012046›Full record

ArticleClinical and experimental nephrology2008

Proposal of podocytic infolding glomerulopathy as a new disease entity: a review of 25 cases from nationwide research in Japan.

Kensuke Joh, Takashi Taguchi, Hidekazu Shigematsu, Yutaka Kobayashi, Hiroshi Sato, Shinichi Nishi, Ritsuko Katafuchi, Shinsuke Nomura, Yoshihide Fujigaki, Yasunori Utsunomiya and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. IgA nephropathy with podocytic infolding glomerulopathy.Chronic diseases and translational medicine · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Podocyte Infolding Glomerulopathy, First Case Report From North America.Canadian journal of kidney health and disease · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 12 institutions in 1 country.

Kensuke JohDivision of Renal Pathology, Clinical Research Center, Chiba-East National Hospital, Chiba, 260-8712, Japan. johken@cehprinet.com
Takashi Taguchi
Hidekazu Shigematsu
Yutaka Kobayashi
Hiroshi Sato
Shinichi Nishi
Ritsuko Katafuchi
Shinsuke Nomura
Yoshihide Fujigaki
Yasunori Utsunomiya
Hitoshi Sugiyama
Takao Saito
Hirofumi Makino
Okayama University · JPAkebono (Japan) · JPChiba East Hospital · JPFukuoka Higashi Medical Center · JPFukuoka University · JPHamamatsu University School of Medicine · JPJikei University School of Medicine · JPMie University · JPNagasaki University · JPNiigata University · JPShinshu University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA rare and peculiar glomerulopathy has begun to be recognized in Japan. The Japanese Society of Nephrology has established a research working group and has collected cases from all over Japan in an attempt to understand the complete spectrum of this glomerulopathy.

methodThe diagnostic criterion, which was needed to collect the cases, was proposed as a glomerulopathy showing microspheres or microtubular structures or both associated with podocytic infolding into the glomerular basement membrane (GBM) on electron microscopy. The lesion shows a non-argentaffin hole in the GBM with periodic acid methenamine silver staining and is similar to membranous glomerulonephritis.

resultsTwenty-five cases were collected from 17 institutions. Patients were 20-69 years old (19 women, 6 men). Seventeen patients also had collagen diseases such as lupus nephritis and Sjögren's syndrome. All patients had proteinuria. Proteinuria showed a remission in 15 of 23 patients within 12 months, but proteinuria remained higher than 1.0 g/day in five patients despite different types of therapy. Podocytic infolding including microspheres showed either positive or negative staining for immunoglobulins. Cluster formation of microspheres was found in 4 of 17 patients with collagen disease, and in five out eight patients without collagen disease. Electron-dense deposits in the GBM were also found in 6 of 17 patients with collagen disease but were not found in eight patients without collagen disease.

conclusionSome patients might have a subtype of lupus nephritis, class V, or membranous glomerulonephritis. However, we propose a new disease entity, podocytic infolding glomerulopathy, as a common basis of all 25 patients, because we suspect that microspheres or microtubular structures or both can be derived from podocytic infolding.

Indexed as

AdultAgedFemaleGlomerular Basement MembraneHumansKidney DiseasesMaleMicrospheresMiddle AgedPodocytes

Identifiers

PMID19012046
OpenAlexW1966852028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.